MedPath

Setting of appropriate dosage and comparing the effectiveness of Caffeine and Aminophylline in premature babies with pause of breathing for 15 to 20 seconds

Phase 2
Conditions
Health Condition 1: null- Neonates with Apnea of Prematurity
Registration Number
CTRI/2015/06/005904
Lead Sponsor
Kasturba Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
402
Inclusion Criteria

1. Less than or equal to 34 completed weeks of gestation with less than or equal to 6 apneas in 24 hours , or

2. Any preterm newborn with apneic episode requiring bag and mask ventilation for termination of apnea.

Exclusion Criteria

1.Neonates with secondary causes of apnea ( hypoglycemia , hypocalcemia , hypothermia, seizures , sepsis , Intra Ventricular Hemorrhage , depression from medications)

2.Neonates who are on other drugs that potentiates the toxicity of Methylxanthines

3.Preterm neonates with major congenital anomalies

4.Significant PDA as a cause of apnea (defined as - ductus diameter of 1.5mm and absent/ retrograde diastolic flow in the post-ductal aorta)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath